ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
12 announcements
The company issued a notice for its Annual General Meeting scheduled for September 29, 2026, to consider financial statements, director appointments, and related party transaction approvals.
Tejnaksh Healthcare Limited has submitted its Annual Report for the financial year 2025-26. The filing includes audited standalone and consolidated financial statements along with governance reports.
Tejnaksh Healthcare Ltd will hold its 19th Annual General Meeting on September 29, 2026. The meeting will be conducted via video conferencing to transact ordinary and special business.
Tejnaksh Healthcare Ltd reported revenue from operations of ₹2.7 Cr (+3.8% YoY) and net profit of ₹0.3 Cr (+50.0% YoY) for Q1 FY27.
Tejnaksh Healthcare has scheduled a board meeting for August 13, 2026, to approve the financial results for the quarter ended June 30, 2026.
Tejnaksh Healthcare Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended June 30, 2026.
Tejnaksh Healthcare Limited submitted its Annual Secretarial Compliance Report for FY 2025-26 under SEBI Regulation 24A. The report confirms regulatory adherence with no material penalties or deviations reported.
Tejnaksh Healthcare Ltd reported revenue from operations of ₹2.6 Cr (-18.8% YoY) and net profit of ₹0.3 Cr (-25.0% YoY) for Q4 FY26.
Tejnaksh Healthcare approved audited FY26 financial results with an unmodified auditor's opinion. The board also decided to cancel its previously proposed rights issue due to postponed expansion plans.
Tejnaksh Healthcare scheduled a board meeting on May 30, 2026. Directors will consider and approve audited financial results for the quarter and year ended March 2026.
Tejnaksh Healthcare Limited confirmed it does not qualify as a 'Large Corporate' under SEBI's debt-raising framework for the financial year. The company reported zero outstanding borrowings as of March 31, 2026, and is therefore not subject to mandatory debt security issuance requirements.
Tejnaksh Healthcare Ltd clarified to the BSE that the recent significant movement in its share price is purely market-driven. The company confirmed it has no undisclosed material information and remains in compliance with SEBI Listing Regulations.